Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking.

PURPOSE To determine the relative positional stability of implanted glass-encapsulated circuits (transponders) used in continuous electromagnetic localization and tracking of target volumes during radiation therapy. Ideally, the distances between transponders remains constant over the course of treatment. In this work, we evaluate the accuracy of these conditions. METHODS AND MATERIALS Three transponders were implanted in each of 20 patients. Images (CT scan or X-ray pair) were acquired at 13 time points. These images occurred from the day of implant (2 weeks before simulation) to 4 weeks posttreatment. The distance between transponders was determined from each dataset. The average and standard deviation of each distance were determined, and changes were evaluated over several time periods, including pretreatment and during therapy. RESULTS Of 60 transponders implanted, 58 showed no significant migration from their intended positions. Of the two transponders that did migrate, one appears to have been implanted in the venous plexus, and the other in the urethra, with no clinical consequences to the patients. An analysis that included the planning CT scan and all subsequent distance measurements showed that the standard deviation of intertransponder distances was < or =1.2 mm for up to 1 month after the completion of therapy. CONCLUSIONS Implanted transponders demonstrate the same long-term stability characteristics as implanted gold markers, within statistical uncertainties. As with gold markers, and using the same implant procedure, basic guidelines for the placement of transponders within the prostate help ensure minimal migration.

[1]  Shinichi Shimizu,et al.  Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT). , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Koichi Yamazaki,et al.  Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy. , 2003, International journal of radiation oncology, biology, physics.

[3]  Shinichi Shimizu,et al.  Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. , 2002, International journal of radiation oncology, biology, physics.

[4]  Wilfred Sewchand,et al.  Marker seed migration in prostate localization. , 2002, International journal of radiation oncology, biology, physics.

[5]  J Pouliot,et al.  Robustness and precision of an automatic marker detection algorithm for online prostate daily targeting using a standard V-EPID. , 2003, Medical physics.

[6]  J. Crook,et al.  Prostate motion during standard radiotherapy as assessed by fiducial markers. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Randall K Ten Haken,et al.  Daily prostate targeting using implanted radiopaque markers. , 2001, International journal of radiation oncology, biology, physics.

[8]  Hiroki Shirato,et al.  Feasibility of synchronization of real-time tumor-tracking radiotherapy and intensity-modulated radiotherapy from viewpoint of excessive dose from fluoroscopy. , 2004, International journal of radiation oncology, biology, physics.

[9]  Patrick A Kupelian,et al.  Influence of intrafraction motion on margins for prostate radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[10]  K L Lam,et al.  Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. , 1995, International journal of radiation oncology, biology, physics.

[11]  Jean Pouliot,et al.  (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device. , 2003, International journal of radiation oncology, biology, physics.

[12]  David A Jaffray,et al.  On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. , 2004, International journal of radiation oncology, biology, physics.

[13]  James M. Balter,et al.  Demonstration of accurate localization and continuous tracking of implantable wireless electromagnetic transponders , 2003 .

[14]  P Price,et al.  Developments in and experience of kilovoltage X-ray cone beam image-guided radiotherapy. , 2006, The British journal of radiology.

[15]  J Pouliot,et al.  Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. , 1997, International journal of radiation oncology, biology, physics.

[16]  John Wong,et al.  Accuracy of a wireless localization system for radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[17]  Jan J W Lagendijk,et al.  Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  P Hofman,et al.  Detection of fiducial gold markers for automatic on-line megavoltage position verification using a marker extraction kernel (MEK). , 2000, International journal of radiation oncology, biology, physics.

[19]  R K Ten Haken,et al.  The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[20]  Patrick A Kupelian,et al.  Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability. , 2005, International journal of radiation oncology, biology, physics.